Skip to content

Modern Urodynamics System Efficacy (MUSE) Study

Modern Urodynamics System Efficacy (MUSE) Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05959655
Acronym
MUSE
Enrollment
38
Registered
2023-07-25
Start date
2023-08-21
Completion date
2024-04-18
Last updated
2025-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urodynamics, Urologic Diseases

Keywords

Lower Urinary Tract Dysfunction, Urinary Incontinence, Overactive Bladder, Urodynamics, Uroflowmetry

Brief summary

The goal of this prospective trial is to evaluate the feasibility, efficacy, and safety of the Glean Urodynamics System (GUS) for use in the clinic to collect vesical pressure data in adult males and females with lower urinary tract symptoms. The main question\[s\] it aims to answer are: • What is the feasibility, efficacy, and safety of GUS for use in clinical to collect vesical pressure data in adult males and females with lower urinary tract symptoms? Participants will undergo a planned conventional urodynamics exam after which the Glean Sensor will be inserted and ambulatory urodynamics will be performed with the sensor indwelling in the bladder after which the sensor will be removed.

Interventions

Wireless, catheter-free urodynamics system

Sponsors

Bright Uro
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female patient must be ≥ 18 years of age * Patient must have a diagnosis of LUTD * Patient must be scheduled for or recommended for cUDS * Patient is able to tolerate 18Fr catheterization * Patient or patient's legally authorized representative is able to provide informed consent

Exclusion criteria

* Pregnant (as confirmed by urine pregnancy test) or breastfeeding, pregnant within the past 6 months or intend to become pregnant during the study period. * Patient has a symptomatic UTI based on CDC guidance (see below) * Subjects who, at the principal investigator's determination, would not be appropriate for this study.

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Participants With Insertion Successduring the insertion procedure of a devicePercent of insertion attempts of the Glean sensor deemed successful
Percentage of Participants With a Device-related SAEup to 2 weeksDevice-related serious adverse events
Percentage of Participants With Removal Successduring the removal procedure of a devicePercent of removal attempts of the Glean sensor deemed successful

Secondary

MeasureTime frameDescription
Percentage of Participants Rating Overall Comfort of Glean Urodynamics as Comfortable or Extremely Comfortableasked at end of Glean Urodynamics procedureNumber of participants rating the overall comfort of Glean Urodynamics at comfortable or extremely comfortable

Countries

United States

Participant flow

Participants by arm

ArmCount
Glean Urodynamics System
Wireless, catheter-free urodynamics system
38
Total38

Baseline characteristics

CharacteristicGlean Urodynamics System
Age, Customized
Age
64 Years
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
35 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
6 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
32 Participants
Sex: Female, Male
Female
17 Participants
Sex: Female, Male
Male
21 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 380 / 32
other
Total, other adverse events
12 / 387 / 32
serious
Total, serious adverse events
0 / 380 / 32

Outcome results

Primary

Percentage of Participants With a Device-related SAE

Device-related serious adverse events

Time frame: up to 2 weeks

Population: Number of participants undergoing Glean Urodynamics

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Glean Urodynamics SystemPercentage of Participants With a Device-related SAE0 Participants
Primary

Percentage of Participants With Insertion Success

Percent of insertion attempts of the Glean sensor deemed successful

Time frame: during the insertion procedure of a device

Population: 33/34 participants who underwent conventional urodynamics underwent an insertion attempt with the Glean Urodynamics System.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Glean Urodynamics SystemPercentage of Participants With Insertion Success32 Participants
Primary

Percentage of Participants With Removal Success

Percent of removal attempts of the Glean sensor deemed successful

Time frame: during the removal procedure of a device

Population: 32 participants had Glean successfully inserted and thus all had a successful removal.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Glean Urodynamics SystemPercentage of Participants With Removal Success32 Participants
Secondary

Percentage of Participants Rating Overall Comfort of Glean Urodynamics as Comfortable or Extremely Comfortable

Number of participants rating the overall comfort of Glean Urodynamics at comfortable or extremely comfortable

Time frame: asked at end of Glean Urodynamics procedure

Population: Number of participants who experienced Glean Urodynamics and completed the survey at the end of the urodynamics study visit

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Glean Urodynamics SystemPercentage of Participants Rating Overall Comfort of Glean Urodynamics as Comfortable or Extremely Comfortable13 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026